This is not the most recent version of the article. View current version (12 DEC 2012)

Intervention Review

Oral versus Intravenous Steroids for Treatment of Relapses in Multiple Sclerosis

  1. Jodie M Burton1,*,
  2. Paul W O'Connor1,
  3. Marika Hohol1,
  4. Joseph Beyene2

Editorial Group: Cochrane Multiple Sclerosis Group

Published Online: 8 JUL 2009

Assessed as up-to-date: 31 JUL 2008

DOI: 10.1002/14651858.CD006921.pub2


How to Cite

Burton JM, O'Connor PW, Hohol M, Beyene J. Oral versus Intravenous Steroids for Treatment of Relapses in Multiple Sclerosis. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD006921. DOI: 10.1002/14651858.CD006921.pub2.

Author Information

  1. 1

    St. Michael's Hospital, Division of Neurology, Toronto, Ontario, Canada

  2. 2

    The Hospital for Sick Children, Population Health Sciences, Toronto, Ontario, Canada

*Jodie M Burton, Division of Neurology, St. Michael's Hospital, 30 Bond Street, Toronto, Ontario, M5B 1W8, Canada. burtonj@smh.toronto.on.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 8 JUL 2009

SEARCH

This is not the most recent version of the article. View current version (12 DEC 2012)

  1. Current Version

    Oral versus intravenous steroids for treatment of relapses in multiple sclerosis

    Jodie M Burton, Paul W O'Connor, Marika Hohol and Joseph Beyene

    Version of Record online: 12 DEC 2012 | DOI: 10.1002/14651858.CD006921.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Oral versus Intravenous Steroids for Treatment of Relapses in Multiple Sclerosis

    Jodie M Burton, Paul W O'Connor, Marika Hohol and Joseph Beyene

    Version of Record online: 8 JUL 2009 | DOI: 10.1002/14651858.CD006921.pub2

  2. Version 1

    Oral versus Intravenous Steroids for Treatment of Relapses in Multiple Sclerosis

    Jodie Melissa Burton, Paul W O'Connor, Marika Hohol and Joseph Beyene

    Version of Record online: 23 JAN 2008 | DOI: 10.1002/14651858.CD006921